Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
M. B. Barnkob, K. Vitting-Seerup, L. R. Olsen
The paper examines protein isoform switching in solid cancers as a challenge and opportunity for CAR therapy, highlighting its impact on tumor relapse.
bioRxiv · Mar 2, 2022Cancer Biology